Navigation Links
Uniform Advantage Partners with Living Beyond Breast Cancer for Breast Cancer Awareness
Date:9/17/2019

Uniform Advantage (UA), a leader in the apparel industry will be partnering with Living Beyond Breast Cancer to raise funds for Breast Cancer programs and services.

This year, more than 271,000 Americans will be diagnosed with breast cancer, and more than 42,000 will die of the disease. During the month of October 2019, Uniform Advantage will donate $5 for every unique use of #UAScrubsforLBBC in conjunction with tagging @uniformadvantage across Facebook and Instagram. All proceeds will be donated to the Living Beyond Breast Cancer organization.

“Uniform Advantage recognizes that Breast Cancer has impacted us all,” stated Susan Masimore, CEO of Uniform Advantage. “Research, awareness and support can bring us closer to finding a cure for this disease. Supporting those who support others is part of our company mission to contribute towards the goal of fighting cancer so that people can live long, fulfilling lives.”

Living Beyond Breast Cancer provides trusted information and a community of support for women diagnosed with breast cancer and for those who care about them.

UA has donated more than $14,000 to Living Beyond Breast Cancer, in addition to donating more than $50,000 to ACS Making Strides Against Breast Cancer. To find out more about the history and mission of Living Beyond Breast Cancer, please visit LBBC.ORG.

For more information on Uniform Advantage’s action to help and support breast cancer awareness visit the UA Gives Back page.

About Uniform Advantage                                     
Uniform Advantage has represented style, quality and, above all, customer satisfaction for more than 30 years. As the first division of UA Brands, the chain was launched with a single South Florida store in 1985. Today, the company operates 29 retail locations in key markets across the U.S.; e-commerce and print catalog divisions; plus designs and manufactures its own proprietary healthcare apparel lines. The company’s corporate office is based in Plantation, Florida with a distribution center near Atlanta, Georgia. Learn more at http://www.UniformAdvantage.com or by calling 800-283-8708.

Read the full story at https://www.prweb.com/releases/uniform_advantage_partners_with_living_beyond_breast_cancer_for_breast_cancer_awareness/prweb16578401.htm.


'/>"/>
Source: PRWeb
Copyright©2019 Vocus, Inc.
All rights reserved


Related medicine technology :

1. AACC Calls for Uniformity in Lab Test Results
2. DigiPath Labs CSO Dr. Cindy Orser Calls for Uniform Standards for Cannabis Safety Testing
3. Workrite Uniforms New FR/CP Lab Coat Revolutionizes Safety
4. Lawsuit Filed by Millennium Dental Technologies, Inc against Fotona, LLC for Violations of Californias Uniform Trade Secrets Act
5. Strategic Partners, Inc., and Japanese Uniform Company FOLK Co. Ltd Announce Exclusive Partnership
6. Thought-Leader Opinion and Clinical Data Indicate that Emerging Agents from Two Drug Classes Have Efficacy Advantages Over Currently Used Therapies for HR-Positive, HER2-Negative Breast Cancer
7. Royalty Pharma Issues Investor Presentation Highlighting The Strategic And Financial Advantages Of Its Offer To Acquire Elan For $12.50 Per Share In Cash
8. Emerging Targeted Therapies Offer Efficacy Advantages Over Currently Used Chemotherapies for Platinum-Resistant Advanced Ovarian Cancer
9. Tafinlar in Combination with Mekinist and Nivolumab Have Considerable Efficacy and Tolerability Advantages Over Currently Used Therapies for the Treatment of Unresectable Malignant Melanoma
10. In Terms of Effect on Overall Survival, Current and Emerging Therapies Have No Advantage Over Avastin/FOLFIRI in the Treatment of Second-Line Metastatic Colorectal Cancer, According to Clinical Data and Thought Leader Opinion
11. Efficacy Advantages and Long-Term Cost Savings Will Help Optimize Reimbursement in the EU5 for Type 2 Diabetes Agents
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/19/2019)... ... October 18, 2019 , ... A new study ... suggests adalimumab use in pregnancy was not associated with an increased risk for ... delivery. The findings were published today in the Public Library of ...
(Date:10/17/2019)... Calif. (PRWEB) , ... October 17, 2019 , ... Women’s ... of its Biocell brand of textured implants is the subject of a September 24 ... F.A.C.S., aka Dr. J says that the Allergan recall has revived a number of ...
(Date:10/15/2019)... ... October 15, 2019 , ... Twiggy Bean, Ph.D., wanted to educate others about ... battles make better decisions and become truly child focused. This objective prompted her to ... and STOP the cycle! Don’t be a divorce bully!” (published by Balboa Press), a ...
Breaking Medicine Technology:
(Date:10/19/2019)... , ... October 18, 2019 , ... Today, Guide ... or have low vision by creating exceptional partnerships between people, guide dogs and communities, ... Over 150 reunion attendees are coming together as a community for the event to ...
(Date:10/17/2019)... ... ... Whole Foods Market, along with Austin leaders, has joined forces with Blue ... in-depth assessment by the Blue Zones team of the Austin Metro area and population ... live, work, grow up, and grow old. , Blue Zones is based on research ...
(Date:10/15/2019)... (PRWEB) , ... October 15, 2019 , ... Genomenon® ... partnership with SOPHiA GENETICS that includes incorporating the Mastermind® Genomic Search ... puts the most up-to-date genomic research at the fingertips of clinical researchers performing genomic ...
(Date:10/10/2019)... SARASOTA, Fla. (PRWEB) , ... October 10, 2019 , ... ... in the state (source: OMMU ), has announced the grand opening of its ... Saturday, Oct. 12 at 1198 Beach Blvd., Suite 4 in Jacksonville Beach. , Located ...
(Date:10/8/2019)... ... ... What unique insights can three former Surgeons General of the United States ... That question will be answered at ICAA 2019: Shaping the Future of Wellness, this ... take place October 10-12, 2019, at the Gaylord Palms Resort and Convention Center in ...
Breaking Medicine News(10 mins):